Drew DA, Weiner DE, Sarnak MJ (2019) Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis 74(6):782–790. https://doi.org/10.1053/j.ajkd.2019.05.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL (2006) Cognitive impairment in hemodialysis patients is common. Neurology 67(2):216–223. https://doi.org/10.1212/01.wnl.0000225182.15532.40

Article  CAS  PubMed  Google Scholar 

Murray AM (2008) Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 15(2):123–132. https://doi.org/10.1053/j.ackd.2008.01.010

Article  PubMed  PubMed Central  Google Scholar 

van Sandwijk MS, Ten Berge IJM, Caan MWA, Düring M, van Gool WA, Majoie CBLM, Mutsaerts HMM, Schmand BA, Schrantee A, de Sonneville LMJ, Bemelman FJ (2020) Cognitive improvement after kidney transplantation is associated with structural and functional changes on MRI. Transplant Direct 6(3):e531. https://doi.org/10.1097/TXD.0000000000000976

Article  PubMed  PubMed Central  Google Scholar 

De Deyn PP et al (1995) Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27:227–237. https://doi.org/10.1016/0197-0186(95)00041-6

Article  PubMed  Google Scholar 

De Deyn PP, Vanholder R, Eloot S, Glorieux G (2009) Guanidino compounds as uremic (neuro)toxins. Semin Dial 22(4):340–345. https://doi.org/10.1111/j.1525-139X.2009.00577.x

Article  PubMed  Google Scholar 

Bobot M, Thomas L, Moyon A, Fernandez S, McKay N, Balasse L, Garrigue P, Brige P, Chopinet S, Poitevin S, Cérini C, Brunet P, Dignat-George F, Burtey S, Guillet B, Hache G (2020) Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol 31(7):1509–1521

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazumder MK, Giri A, Kumar S, Borah A (2016) A highly reproducible mice model of chronic kidney disease: evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci 161:27–36. https://doi.org/10.1016/j.lfs.2016.07.020

Article  CAS  PubMed  Google Scholar 

Jing W, Jabbari B, Vaziri ND (2018) Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier. Am J Transl Res 10(7):2137–2147

CAS  PubMed  PubMed Central  Google Scholar 

Hernandez L, Ward LJ, Arefin S, Ebert T, Laucyte-Cibulskiene A; GOING-FWD Collaborators; Heimbürger O, Barany P, Wennberg L, Stenvinkel P, Kublickiene K (2022) Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci Rep 12(1):4414. https://doi.org/10.1038/s41598-022-08387-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel) 13(2):142. https://doi.org/10.3390/toxins13020142

Article  CAS  PubMed  Google Scholar 

Hernandez L, Ward LJ, Arefin S, Barany P, Wennberg L, Söderberg M, Bruno S, Cantaluppi V, Stenvinkel P, Kublickiene K (2023) Blood-brain barrier biomarkers before and after kidney transplantation. Int J Mol Sci 24(7):6628. https://doi.org/10.3390/ijms2407662

Article  CAS  PubMed  PubMed Central  Google Scholar 

Natale G, Calabrese V, Marino G, Campanelli F, Urciuolo F, de Iure A, Ghiglieri V, Calabresi P, Bossola M, Picconi B (2021) Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease. Cell Death Discov 7(1):295. https://doi.org/10.1038/s41420-021-00685-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Hooge R, De Deyn PP, Van de Vijver G, Antoons G, Raes A, Van Bogaert PP (1999) Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones. Neurosci Lett 265(2):83–86. https://doi.org/10.1016/s0304-3940(99)00190-1

Article  Google Scholar 

Yu YH, Kim SW, Im H, Oh SW, Cho NJ, Park S, Park DK, Kim DS, Gil HW (2022) Cognitive sequelae and hippocampal dysfunction in chronic kidney disease following 5/6 nephrectomy. Brain Sci 12(7):905. https://doi.org/10.3390/brainsci12070905

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karbowska M, Hermanowicz JM, Tankiewicz-Kwedlo A, Kalaska B, Kaminski TW, Nosek K, Wisniewska RJ, Pawlak D (2020) Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model. Sci Rep 10(1):9483. https://doi.org/10.1038/s41598-020-66421-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe K, Sato E, Mishima E, Watanabe M, Abe T, Takahashi N, Nakayama M (2021) Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease. Heliyon 7(2):e06221. https://doi.org/10.1016/j.heliyon.2021.e06221

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin YT, Wu PH, Tsai YC, Hsu YL, Wang HY, Kuo MC, Kuo PL, Hwang SJ (2019) Indoxyl sulfate induces apoptosis through oxidative stress and mitogen-activated protein kinase signaling pathway inhibition in human astrocytes. J Clin Med 8(2):191. https://doi.org/10.3390/jcm8020191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeh YC, Huang MF, Liang SS, Hwang SJ, Tsai JC, Liu TL, Wu PH, Yang YH, Kuo KC, Kuo MC, Chen CS (2016) Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology 53:148–152. https://doi.org/10.1016/j.neuro.2016.01.006

Article  CAS  PubMed  Google Scholar 

Lin YT, Wu PH, Lee HH, Mubanga M, Chen CS, Kuo MC, Chiu YW, Kuo PL, Hwang SJ (2019) Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis. Neurotoxicology 73:85–91. https://doi.org/10.1016/j.neuro.2019.02.019

Article  CAS  PubMed  Google Scholar